Denali Therapeutics Inc.

DNLI | NASDAQ

Price Alert Chart Builder DCF Calculator

$21.46

+$0.99 (+4.84%)

Sep 22, 2026, 12:47 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-512.54M	-422.77M	-145.22M	-325.99M	-290.58M	71.14M
Depreciation & Amortization	14.81M	8.99M	16.73M	10.38M	8.59M	8.53M
Stock-Based Compensation	99.63M	102.88M	108.1M	99.85M	85.25M	50.35M
Other Working Capital	7.67M	15.5M	-292.36M	-26.3M	-24.12M	290.02M
Other Non-Cash Items	-14.65M	-53.73M	-47.67M	-4.93M	5.76M	-2.32M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	55K
Change in Working Capital	149K	16.94M	-289.93M	-24.03M	-20.41M	288.4M
Operating Cash Flow	-412.6M	-347.69M	-357.99M	-244.72M	-211.39M	416.15M
Capital Expenditures	-9.5M	-15.91M	-12.94M	-17.83M	-8.5M	-3.1M
Cash Acquisitions	n/a	n/a	n/a	123.55M	n/a	620.11M
Purchase of Investments	-441.26M	-1.23B	-1.81B	-1.12B	-1.42B	-1.29B
Sales Maturities Of Investments	706.05M	1.16B	2.08B	991.49M	1.41B	665.36M
Other Investing Acitivies	n/a	n/a	n/a	-123.55M	n/a	-620.11M
Investing Cash Flow	255.28M	-88.76M	249.31M	-141.39M	-21.63M	-623.21M
Debt Repayment	-8.17M	-32.34M	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	17.39M	n/a	14.46M	n/a	20.66M
Financial Cash Flow	189.22M	484.3M	17.82M	310.67M	19.35M	634.75M
Net Cash Flow	31.9M	47.85M	-90.94M	-75.43M	-213.67M	427.7M
Free Cash Flow	-422.1M	-363.61M	-370.93M	-262.55M	-219.89M	413.06M
Adj. Free Cash Flow	-521.74M	-466.48M	-479.03M	-362.4M	-305.14M	362.71M
Maintenance CapEx	-9.5M	-15.91M	n/a	n/a	-8.5M	n/a
Growth CapEx	n/a	n/a	-12.94M	-17.83M	n/a	-3.1M
Owner Earnings	-422.1M	-363.61M	-357.99M	-244.72M	-219.89M	416.15M